✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

JW (Cayman) Therapeutics Co Ltd

Common Name
JW (Cayman) Therapeutics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
314
Ticker
2126
Exchange
Hong Kong Exchanges and Clearing Limited
Description
JW (Cayman) Therapeutics Co. Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing cell-based immunotherapies. The company primarily engages in the field of onc...

JW (Cayman) Therapeutics's Climate Target Data Preview

As of 2025, JW (Cayman) Therapeutics has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into JW (Cayman) Therapeutics's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
-40%a
2025
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/climate-targets?ticker=2126"

Verified Sources Behind JW (Cayman) Therapeutics’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. JW (Cayman) Therapeutics's ESG Report 2025

Insights into JW (Cayman) Therapeutics's Greenhouse Gas Emissions Pathways

As of 2025, JW (Cayman) Therapeutics has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a

Does JW (Cayman) Therapeutics have a target to reduce the emissions from its operations?

As of 2025, JW (Cayman) Therapeutics has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

JW (Cayman) Therapeutics's most ambitious operational target is to reduce these emissions by 40% by 2025, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue in 2021.a

JW (Cayman) Therapeutics has already surpassed its operational emissions reduction target, with 2025 levels falling below the 2025 value, achieving its climate goal ahead of schedule.a

JW (Cayman) Therapeutics's Operational (Scope 1+2) Emissions Pathway

2021202500000BaselineCurrent (-92%)Target 2025 (-40%)
Want Full Access to JW (Cayman) Therapeutics's Climate Targets Dataset?
Start 30-Day Free Trial